WTAP increases m6A modification on PD-1 mRNA, promoting YTHDF1-mediated PD-1 translation, thereby suppressing CD8+ T cell proliferation and immune activity, leading to exhaustion and enhanced tumor malignancy. Here, CD8A is linked to neoplasm.